Our research team assigns Neutral ratings to strategies they’re not confident will outperform a relevant index, or most peers, over a market cycle on a risk-adjusted basis. Managers Patrick ...

On July 12, 2024, Alger amended the prospectuses for Alger ... But that’s not always the case. The strategy’s recent foray into biotech stocks raises eyebrows. Of the January 2024 US mutual ...